These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 7730606

  • 1. cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation.
    Francis ML, Okazaki I, Moss J, Kurosky A, Pecanha LM, Mond JJ.
    J Immunol; 1995 May 15; 154(10):4956-64. PubMed ID: 7730606
    [Abstract] [Full Text] [Related]

  • 2. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
    Lycke NY.
    J Immunol; 1993 Jun 01; 150(11):4810-21. PubMed ID: 8388421
    [Abstract] [Full Text] [Related]

  • 3. cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation.
    Francis ML, Moss J, Fitz TA, Mond JJ.
    J Immunol; 1990 Nov 15; 145(10):3162-9. PubMed ID: 2172379
    [Abstract] [Full Text] [Related]

  • 4. Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.
    Francis ML, Ryan J, Jobling MG, Holmes RK, Moss J, Mond JJ.
    J Immunol; 1992 Apr 01; 148(7):1999-2005. PubMed ID: 1312102
    [Abstract] [Full Text] [Related]

  • 5. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    Anderson DL, Tsoukas CD.
    J Immunol; 1989 Dec 01; 143(11):3647-52. PubMed ID: 2555413
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD, Turo K, Dieleman LA, Beagley KW, Elson CO.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [Abstract] [Full Text] [Related]

  • 7. Selective effects of cholera toxin on the activation of mouse B cells by different polyclonal activators.
    Klaus GG, Vondy K, Holman M.
    Eur J Immunol; 1987 Dec 15; 17(12):1787-92. PubMed ID: 2826173
    [Abstract] [Full Text] [Related]

  • 8. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation.
    Lycke N, Severinson E, Strober W.
    J Immunol; 1990 Nov 15; 145(10):3316-24. PubMed ID: 1700007
    [Abstract] [Full Text] [Related]

  • 9. Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation.
    Anastassiou ED, Yamada H, Francis ML, Mond JJ, Tsokos GC.
    J Immunol; 1990 Oct 15; 145(8):2375-80. PubMed ID: 2120330
    [Abstract] [Full Text] [Related]

  • 10. Correlation between ribosylation of pertussis toxin substrates and inhibition of peptidoglycan-, muramyl dipeptide- and lipopolysaccharide-induced mitogenic stimulation in B lymphocytes.
    Dziarski R.
    Eur J Immunol; 1989 Jan 15; 19(1):125-30. PubMed ID: 2537732
    [Abstract] [Full Text] [Related]

  • 11. B cell superstimulatory influenza virus (H2-subtype) induces B cell proliferation by a PKC-activating, Ca(2+)-independent mechanism.
    Rott O, Charreire J, Semichon M, Bismuth G, Cash E.
    J Immunol; 1995 Mar 01; 154(5):2092-103. PubMed ID: 7868886
    [Abstract] [Full Text] [Related]

  • 12. Cholera toxin discriminates between murine T lymphocyte proliferation stimulated by activators of protein kinase C and proliferation stimulated by IL-2. Possible role for intracellular cAMP.
    Kim DK, Nau GJ, Lancki DW, Dawson G, Fitch FW.
    J Immunol; 1988 Nov 15; 141(10):3429-37. PubMed ID: 2846687
    [Abstract] [Full Text] [Related]

  • 13. Cholera toxin induces tumor necrosis factor alpha production in human monocytes.
    Yan Z, Yang DC, Jett M.
    Mol Cell Biol Res Commun; 1999 Aug 15; 2(2):124-30. PubMed ID: 10542136
    [Abstract] [Full Text] [Related]

  • 14. Effect of bacterial toxins on human B cell activation. II. Mitogenic activity of the B subunit of cholera toxin.
    Dugas B, Paul-Eugène N, Génot E, Mencia-Huerta JM, Braquet P, Kolb JP.
    Eur J Immunol; 1991 Feb 15; 21(2):495-500. PubMed ID: 1847876
    [Abstract] [Full Text] [Related]

  • 15. Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis.
    Roper RL, Conrad DH, Brown DM, Warner GL, Phipps RP.
    J Immunol; 1990 Oct 15; 145(8):2644-51. PubMed ID: 2170523
    [Abstract] [Full Text] [Related]

  • 16. Interleukin 2 counteracts the inhibition of cytotoxic T lymphocytes by cholera toxin in vitro and in vivo.
    Moscovitch-Lopatin M, Petrillo RJ, Pankewycz OG, Hadro E, Bleackley CR, Strom TB, Wieder KJ.
    Eur J Immunol; 1991 Jun 15; 21(6):1439-44. PubMed ID: 1646113
    [Abstract] [Full Text] [Related]

  • 17. IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein.
    Sebok K, Woodside D, al-Aoukaty A, Ho AD, Gluck S, Maghazachi AA.
    J Immunol; 1993 Feb 15; 150(4):1524-34. PubMed ID: 8381837
    [Abstract] [Full Text] [Related]

  • 18. Stimulatory guanine nucleotide binding protein in pig epidermis: transient increase of the 45KDA cholera toxin substrate (Gs alpha) in the tape stripping-induced hyperproliferative state.
    Tsutsui M, Tamura T, Takahashi H, Hashimoto Y, Iizuka H.
    Epithelial Cell Biol; 1994 Feb 15; 3(4):161-7. PubMed ID: 7550608
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial cell barrier dysfunction.
    Patterson CE, Davis HW, Schaphorst KL, Garcia JG.
    Microvasc Res; 1994 Sep 15; 48(2):212-35. PubMed ID: 7854206
    [Abstract] [Full Text] [Related]

  • 20. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo.
    Lycke N, Bromander AK, Ekman L, Karlsson U, Holmgren J.
    J Immunol; 1989 Jan 01; 142(1):20-7. PubMed ID: 2783324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.